Doximity Inc.'s management recently addressed investors, highlighting advancements in their AI-powered medical tools, including the DoxGPT reference platform and the Doximity Scribe, a HIPAA-compliant ambient note-taking tool. The company reported a significant increase in quarterly active users for Scribe and integrated the tool with their telehealth platform, Doximity Dialer, streamlining the documentation process for clinicians. Management emphasized their commitment to reducing administrative burdens for healthcare professionals and discussed the long-term growth potential of their AI suite. The full remarks and related financial information are available on the company's investor relations website at investors.doximity.com.